Page 5 - Diffusion Pharmaceuticals News Today

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 9,700 shares, an increase of 148.7% from the April 30th total of 3,900 shares. Approximately 0.5% of the shares of the company are sold short. Based on […]

Raven Jaeger, M.S. named Chief Regulatory Officer and Andrew Cunningham, M.D., MRCPI, named Senior Vice President, Clinical DevelopmentLA JOLLA, Calif., May 23, 2023 -- CalciMedica Inc. , a... | May 23, 2023

StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report sent to investors on Sunday. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Price Performance Shares of Diffusion Pharmaceuticals stock traded up $0.14 on Friday, hitting $4.13. The stock had a trading volume of 7,272 shares, […]

StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note issued to investors on Saturday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Down 2.2 % Shares of DFFN stock opened at $3.97 on Friday. The business has a 50 day moving average of […]

StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Price Performance Shares of DFFN opened at $3.97 on Friday. The firm has a market cap of $8.10 million, a PE ratio […]

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the recipient of a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 3,900 shares, a growth of 18.2% from the April 15th total of 3,300 shares. Based on an average trading volume of 6,800 shares, the […]

Research analysts at StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report issued on Saturday. The firm set a “hold” rating on the stock. Diffusion Pharmaceuticals Stock Up 3.3 % Shares of DFFN opened at $4.06 on Friday. Diffusion Pharmaceuticals has a 52-week low of $3.65 and a 52-week […]

Stock Analysts’ new coverage for Saturday, May 13th: StockNews.com initiated coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP). StockNews.com issued a hold rating on the stock. StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). They issued a hold rating on the stock. StockNews.com started coverage on shares of Aerojet Rocketdyne (NYSE:AJRD). StockNews.com issued a hold […]

/PRNewswire/ -- EIP Pharma Inc., a clinical stage company focused on developing treatments for neurodegenerative diseases, today announced that the Companys...

EIP Pharma to Present at JMP Securities Life Sciences Conference BOSTON, MA - May 11, 2023 - EIP Pharma Inc., a clinical stage company focused on developing treatments for... | May 11, 2023